As of November 2026 Novavax has a market cap of A$2.59 Billion. This makes Novavax the world's 5114th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2026 the market cap of Novavax was reported to be: